We extended this observation to the brain of an NPC patient and showed the efficacy of FAAH inhibition to reduce not only SM levels in NPC patient‐derived cells but also cholesterol accumulation, which is a pathologic hallmark of the disease (Devlin et al, 2010). This evidence concerns the gene FAAH and nasopharyngeal carcinoma.